8-K/ALeadership Changes

CARDINAL HEALTH INC 8-K/A Report, Executive Changes (Jan 25, 2010)

Filed January 25, 2010For Securities:CAH

Summary

This 8-K/A filing from Cardinal Health Inc. (CAH) serves as an amendment to a prior report, primarily detailing the appointment of two new directors to the company's Board and their committee assignments. Specifically, Carrie S. Cox, formerly of Schering-Plough, has been appointed to the Audit Committee, reinforcing her role as a director elected in December 2009. Additionally, Dr. James J. Mongan, recently retired CEO of Partners HealthCare Systems, Inc., has been elected to the Board and also appointed to the Audit Committee. These appointments signal potential strategic insights and oversight capabilities being brought to Cardinal Health's governance. The inclusion of individuals with significant executive and healthcare system experience in leadership roles, particularly within the Audit Committee, suggests a focus on financial scrutiny and operational integrity. Investors should note the compensation details for Dr. Mongan, including a restricted share unit grant, which aligns director interests with shareholder value.

Key Highlights

  • 1Amendment to a previous 8-K filing concerning director appointments and committee assignments.
  • 2Carrie S. Cox appointed to the Audit Committee of the Board of Directors, effective January 22, 2010.
  • 3Dr. James J. Mongan elected to the Board of Directors until the 2010 annual meeting and appointed to the Audit Committee, effective January 22, 2010.
  • 4Dr. Mongan's prior experience includes serving as President and Chief Executive Officer of Partners HealthCare Systems, Inc.
  • 5Dr. Mongan will receive standard non-management director compensation, including an equity grant of Restricted Share Units (RSUs) valued at $120,000.
  • 6The RSUs granted to Dr. Mongan will vest in full one year from the grant date and be settled in common shares.
  • 7Dr. Mongan will also enter into Cardinal Health's standard directors' indemnification agreement.

Frequently Asked Questions

This filing is an amendment to a previous 8-K report. Its main purpose is to provide updated information regarding the appointment of two new directors, Carrie S. Cox and Dr. James J. Mongan, to the Board of Directors and their subsequent assignments to the Audit Committee.

The appointment of two new members, Ms. Cox and Dr. Mongan, to the Audit Committee is significant as it suggests a strengthening of the board's oversight on financial reporting, internal controls, and risk management. Their diverse and extensive experience in the healthcare and pharmaceutical sectors could bring valuable perspectives to these critical areas.

Dr. Mongan will receive compensation according to the standard arrangements for non-management directors. This includes an initial equity grant of Restricted Share Units (RSUs) valued at $120,000, based on the closing share price on the grant date. These RSUs will vest in full one year after the grant date and will be settled in Cardinal Health common shares. He will also receive a standard directors' indemnification agreement.

Carrie S. Cox previously held executive positions at Schering-Plough Corporation, including Executive Vice President and President, Global Pharmaceuticals, before its merger with Merck. Dr. James J. Mongan is a medical doctor and recently retired as President and Chief Executive Officer of Partners HealthCare Systems, Inc., a major integrated health care system.